RxDoctor Payments Data

Alexander Boucher, MD

Pediatric Hematology-Oncology · Minneapolis, MNNPI 1194083675

Payments from drug & device makers

What this record shows

That places this record below the midpoint for pediatric hematology-oncology clinicians in MN, where the typical reported total is $611.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$352,384in research payments, 2019–2025

Across 123 payments — averaging $2864.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$177K
  • CSL Behring$175K

How this compares

$0 in reported general payments places this provider in the 10th percentile of 60 pediatric hematology-oncology providers in Minnesota.

See all pediatric hematology-oncology providers in Minnesota

Medicare billing

Part B allowed, 2024
$6,732
Medicare patients
27
Services billed
81

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl45$301

Paid to pharmacies, not to this prescriber.

Other pediatric hematology-oncology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →